The mission of the Graft Processing & Cellular Therapy Committee is to recommend to the Executive Committee policies, programs, and actions in the area of any/all issues pertaining to the handling of a harvested product: storage, preparation and manipulation equipment, product transportation practices, and documentation within a member cell processing center; this includes the conduct of individuals and processes related to these procedures and practices. The Graft Processing and Cellular Therapies Committee will also recommend and provide support to the Executive Committee the increasingly important and related area of cellular therapy.
Meetings & Teleconfereces
The group meets annually and by telephone conferences throughout the year.
The Graft Processing and Cellular Therapy Committee participated in the following projects:
- Co-authored a manuscript on the WHO initiative, Medical Products of Human Origin (MPHO). The manuscript was ratified by WBMT, ISBT, International Council for Commonality in Blood Banking Automation (ICCBBA), and The Transplant Society (TTS).
- Publication: Essential requirements for setting up a stem cell processing laboratory.
The Graft Processing and Cellular Therapy Committee continues to work on the following projects:
- Partner with the International Society of Cellular Therapy (ISCT) on the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies project. Mickey Koh was appointed one of three Vice Chairs in this project.
- Create a map of Cell Processing laboratory facilities worldwide.
- Collate the practices and results of various centres who have dispensed with cryopreservation in autologous stem cell transplants. This relies on non-cryopreserved stem cells being stored in the fridge for a finite period of time. The Co-Chairs thought it would be important to analyse the data and clinical results from this practice, which is not typically recommended.
- Collaborate with the EBMT Cellular Therapies Working Party and other organisations to produce an activity survey of cellular therapies worldwide.
- Coordinate with FACT and the Joint Accreditation Committee of ISCT and EBMT (JACIE) to introduce step-wise accreditation for laboratories (and transplant programs) in emerging regions under a joint International Accreditation Program.
Want to join us?
Send an e-mail to mail to email@example.com